The Oncodarwinian Hypothesis (OdH) proposes a paradigm shift: cancer is not merely a disease but a potential macro‑immunoadaptive response – a self‑replicating algorithm that can be reprogrammed via AI‑based 3D printed p53 superproteins. Using hypothesis‑generation methods (observation, deductive reasoning), the author presents two theoretical findings: a wireless 3D printed p53 molecular biochip and the dual‑focus (micro‑/macro‑immunological) nature of cancer cells. The core argument: uncontrolled cell division may represent an evolutionary healing attempt that requires deciphering, not just suppression. A workflow for AI‑assisted p53 design (AlphaFold 3, MoluCAD, Blender) and bacterial delivery systems is outlined. Clinical translation remains speculative; experimental validation is needed.
Introduction
The author questions whether cancer has been misrepresented by overspecialization. OdH views cancer as an adaptive, self‑learning evolutionary process that can be managed by AI‑engineered p53 superproteins.
Cancer as Biological Fatalism
Standard oncology: cancer arises from mutations in cell cycle regulators (oncogenes activated, tumor suppressors like p53 inactivated). p53 normally repairs DNA or triggers apoptosis; in cancer it is often deficient.
Cancer as Biological Creativity and AI‑Based 3D Printed p53
OdH reframes uncontrolled division as an adaptive immune response. The author proposes 3D printing p53 "superproteins" using AI design (AlphaFold 3) and open‑source software (MoluCAD, Blender, Meshmixer) to create a wireless p53 molecular biochip that communicates with an AI algorithm (e.g., ChatGPT) to guide tumor suppression. Synthetic biology (Fussenegger's genetic CPU) and evolutionary medicine provide the theoretical backbone.
Dual‑Focus Immunological Nature of Cancer
OdH distinguishes micro‑immunology (tumor immune evasion) from macro‑immunology (cancer as an ongoing non‑pathological self‑learning process on evolutionary timescales). AI‑printed p53 could accelerate this macro‑immunoadaptive dimension.
AI‑Environmented 3D Protein Printing
The paper reviews AI‑driven protein design (AlphaFold 3, RoseTTAFold) and 3D bioprinting. Proposed delivery: attenuated Salmonella carrying viral genomes and synthetic p53 into tumors (CAPPSID platform).
Clinical Translation and Limitations
This remains speculative. Confirmation bias is a risk; no experimental data are presented. Analogy to Einstein's photon hypothesis, which took years to validate.
Future Directions
Viability tests for p53 as an electrochemical biochip; statistical validation (α=0.05, p<0.05) for tumor inhibition. Interdisciplinary partnerships needed.
Conclusions
The dogma of cancer as merely runaway division must be overcome. Cancer may be a self‑replicating immunoadaptive algorithm whose "source code" – deciphered via AI‑based 3D printed p53 superproteins – can be reprogrammed.
Full text:
https://www.xiahepublishing.com/2472-0712/ERHM-2025-00041
The study was recently published in the Exploratory Research and Hypothesis in Medicine .
Exploratory Research and Hypothesis in Medicine (ERHM) publishes original exploratory research articles and state-of-the-art reviews that focus on novel findings and the most recent scientific advances that support new hypotheses in medicine. The journal accepts a wide range of topics, including innovative diagnostic and therapeutic modalities as well as insightful theories related to the practice of medicine. The exploratory research published in ERHM does not necessarily need to be comprehensive and conclusive, but the study design must be solid, the methodologies must be reliable, the results must be true, and the hypothesis must be rational and justifiable with evidence.
